141 related articles for article (PubMed ID: 9721021)
1. Prolongation of morphine analgesia by competitive NMDA receptor antagonist D-CPPene (SDZ EAA 494) in rats.
Bespalov A; Kudryashova M; Zvartau E
Eur J Pharmacol; 1998 Jun; 351(3):299-305. PubMed ID: 9721021
[TBL] [Abstract][Full Text] [Related]
2. Antinociceptive activity of combination of morphine and NMDA receptor antagonists depends on the inter-injection interval.
Belozertseva IV; Dravolina OA; Neznanova ON; Danysz W; Bespalov AY
Eur J Pharmacol; 2000 May; 396(2-3):77-83. PubMed ID: 10822059
[TBL] [Abstract][Full Text] [Related]
3. Effects of the NMDA receptor antagonist, D-CPPene, on sensitization to the operant decrement produced by naloxone in morphine-treated rats.
Bespalov AY; Medvedev IO; Sukhotina IA; Zvartau EE
Behav Pharmacol; 2001 Apr; 12(2):135-42. PubMed ID: 11396518
[TBL] [Abstract][Full Text] [Related]
4. N-Methyl-D-aspartate receptor antagonists and the development of tolerance to the discriminative stimulus effects of morphine in rats.
Bespalov AY; Balster RL; Beardsley PM
J Pharmacol Exp Ther; 1999 Jul; 290(1):20-7. PubMed ID: 10381755
[TBL] [Abstract][Full Text] [Related]
5. Electrical but not chemical kindling increases sensitivity to some phencyclidine-like behavioral effects induced by the competitive NMDA receptor antagonist D-CPPene in rats.
Wlaź P; Ebert U; Potschka H; Löscher W
Eur J Pharmacol; 1998 Jul; 353(2-3):177-89. PubMed ID: 9726648
[TBL] [Abstract][Full Text] [Related]
6. Pretreatment with morphine potentiates naloxone-conditioned place aversion in mice: effects of NMDA receptor antagonists.
Blokhina EA; Sukhotina IA; Bespalov AY
Eur J Pharmacol; 2000 Oct; 406(2):227-32. PubMed ID: 11020485
[TBL] [Abstract][Full Text] [Related]
7. Effects of NMDA receptor antagonists on acute mu-opioid analgesia in the rat.
Redwine KE; Trujillo KA
Pharmacol Biochem Behav; 2003 Sep; 76(2):361-72. PubMed ID: 14592689
[TBL] [Abstract][Full Text] [Related]
8. Effects of NMDA receptor antagonists on inhibition of morphine tolerance in rats: binding at mu-opioid receptors.
Wong CS; Cherng CH; Luk HN; Ho ST; Tung CS
Eur J Pharmacol; 1996 Feb; 297(1-2):27-33. PubMed ID: 8851162
[TBL] [Abstract][Full Text] [Related]
9. Acute exposure to saccharin reduces morphine analgesia in the the rat: evidence for involvement of N-methyl-D-aspartate and peripheral opioid receptors.
McNally GP; Westbrook RF
Psychopharmacology (Berl); 2000 Mar; 149(1):56-62. PubMed ID: 10789883
[TBL] [Abstract][Full Text] [Related]
10. Effects of N-methyl-D-aspartate receptor antagonists on acute morphine-induced and l-methadone-induced antinociception in mice.
Fischer BD; Carrigan KA; Dykstra LA
J Pain; 2005 Jul; 6(7):425-33. PubMed ID: 15993820
[TBL] [Abstract][Full Text] [Related]
11. Effects of the NMDA receptor antagonist D-CPPene on extracellular levels of dopamine and dopamine and serotonin metabolites in striatum of kindled and non-kindled rats.
Potschka H; Fedrowitz M; Löscher W
Eur J Pharmacol; 1999 Jun; 374(2):175-87. PubMed ID: 10422758
[TBL] [Abstract][Full Text] [Related]
12. Effects of systemic, intracerebral, or intrathecal administration of an N-methyl-D-aspartate receptor antagonist on associative morphine analgesic tolerance and hyperalgesia in rats.
McNally GP; Westbrook RF
Behav Neurosci; 1998 Aug; 112(4):966-78. PubMed ID: 9733203
[TBL] [Abstract][Full Text] [Related]
13. Effects of NMDA receptor channel blockers, dizocilpine and memantine, on the development of opiate analgesic tolerance induced by repeated morphine exposures or social defeats in mice.
Belozertseva IV; Bespalov AYu
Naunyn Schmiedebergs Arch Pharmacol; 1998 Aug; 358(2):270-4. PubMed ID: 9750014
[TBL] [Abstract][Full Text] [Related]
14. Lowered brain stimulation reward thresholds in rats treated with a combination of caffeine and N-methyl-D-aspartate but not alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate or metabotropic glutamate receptor-5 receptor antagonists.
Bespalov A; Dravolina O; Belozertseva I; Adamcio B; Zvartau E
Behav Pharmacol; 2006 Jun; 17(4):295-302. PubMed ID: 16914947
[TBL] [Abstract][Full Text] [Related]
15. Topical opioids in mice: analgesia and reversal of tolerance by a topical N-methyl-D-aspartate antagonist.
Kolesnikov Y; Pasternak GW
J Pharmacol Exp Ther; 1999 Jul; 290(1):247-52. PubMed ID: 10381783
[TBL] [Abstract][Full Text] [Related]
16. Clinically available NMDA antagonist, memantine, attenuates tolerance to analgesic effects of morphine in a mouse tail flick test.
Popik P; Kozela E
Pol J Pharmacol; 1999; 51(3):223-31. PubMed ID: 10600036
[TBL] [Abstract][Full Text] [Related]
17. Effects of competitive and non-competitive N-methyl-D-aspartate (NMDA) antagonists in squirrel monkeys trained to discriminate D-CPPene (SDZ EAA 494) from vehicle.
Wiley JL; Balster RL
Psychopharmacology (Berl); 1994 Nov; 116(3):266-72. PubMed ID: 7892415
[TBL] [Abstract][Full Text] [Related]
18. ACEA-1328, a NMDA receptor/glycine site antagonist, acutely potentiates antinociception and chronically attenuates tolerance induced by morphine.
Lutfy K; Doan P; Weber E
Pharmacol Res; 1999 Nov; 40(5):435-42. PubMed ID: 10527659
[TBL] [Abstract][Full Text] [Related]
19. ACEA-1328, an NMDA receptor antagonist, increases the potency of morphine and U50,488H in the tail flick test in mice.
Lutfy K; Doan P; Nugyen M; Weber E
Pharmacol Res; 1998 Dec; 38(6):453-60. PubMed ID: 9990654
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory effects of MPEP, an mGluR5 antagonist, and memantine, an N-methyl-D-aspartate receptor antagonist, on morphine antinociceptive tolerance in mice.
Kozela E; Pilc A; Popik P
Psychopharmacology (Berl); 2003 Jan; 165(3):245-51. PubMed ID: 12442203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
